Tiamin Life Medical 50 mg/ ml Norwegia - norweski - Statens legemiddelverk

tiamin life medical 50 mg/ ml

life medical aps (1) - tiaminhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml

Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited) Unia Europejska - norweski - EMA (European Medicines Agency)

pemetrexed pfizer (previously known as pemetrexed hospira uk limited)

pfizer europe ma eeig - pemetrexed ditromethamine - carcinoma, non-small-cell lung; mesothelioma - folsyre analoger, antimetabolites - ondartet pleural mesotheliomapemetrexed hospira uk limited i kombinasjon med cisplatin er angitt for behandling av kjemoterapi naive pasienter med inoperabel ondartet pleural mesothelioma. non-small cell lung cancerpemetrexed hospira uk limited i kombinasjon med cisplatin er angitt for det første-linje behandling av pasienter med lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology (se smpc § 5. pemetrexed hospira uk limited er indisert som monoterapi for vedlikehold behandling av lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology hos pasienter med sykdommen har ikke kommet umiddelbart etter platinum-basert kjemoterapi (se smpc § 5. pemetrexed hospira uk limited er indisert som monoterapi for andre-linje behandling av pasienter med lokalt avansert eller metastatisk ikke-liten celle lunge kreft annet enn overveiende plateepitelkreft histology (se smpc § 5.

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Unia Europejska - norweski - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrelhydroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antithrombotic agents - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Adenosin Life Medical 5 mg/ ml Norwegia - norweski - Statens legemiddelverk

adenosin life medical 5 mg/ ml

evolan pharma ab - adenosin - injeksjons-/infusjonsvæske, oppløsning - 5 mg/ ml

Nyxoid Unia Europejska - norweski - EMA (European Medicines Agency)

nyxoid

mundipharma corporation (ireland) limited - nalokson hydrochloride dihydrat - opioid-relaterte lidelser - alle andre terapeutiske produkter - nyxoid er beregnet til umiddelbar administrasjon som akuttapi for kjent eller mistenkt opioid overdose som manifestert av respiratorisk og / eller sentralnervesystemet depresjon i både ikke-medisinske og helsetjenester. nyxoid is indicated in adults and adolescents aged 14 years and over. nyxoid is not a substitute for emergency medical care.

Penthrox 99.9 % Norwegia - norweski - Statens legemiddelverk

penthrox 99.9 %

medical developments ned b.v. - metoksyfluran - væske til inhalasjonsdamp - 99.9 %

Atorvastatin Xiromed 10 mg Norwegia - norweski - Statens legemiddelverk

atorvastatin xiromed 10 mg

medical valley invest ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg

Atorvastatin Xiromed 20 mg Norwegia - norweski - Statens legemiddelverk

atorvastatin xiromed 20 mg

medical valley invest ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg

Atorvastatin Xiromed 40 mg Norwegia - norweski - Statens legemiddelverk

atorvastatin xiromed 40 mg

medical valley invest ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg

Atorvastatin Xiromed 80 mg Norwegia - norweski - Statens legemiddelverk

atorvastatin xiromed 80 mg

medical valley invest ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg